Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

This next iteration of AI is poised to transform biomanufacturing by overcoming challenges that, today, are insurmountable.

NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs ...

The National Unit for Special Crime (National enhed for Særlig Kriminalitet, NSK) has arrested and charged a former employee of Copenhagen Municipality for using the CPR system to help plan a ...

The iShares S&P 500 ETF (ASX: IVV) has been one of the best performers over the last ten years, producing an average annual ...